Live Breaking News & Updates on Micreos Pharmaceuticals

Stay updated with breaking news from Micreos pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Creating New Targeted Antibacterial Products to Help Tackle Antimicrobial Resistance

We speak to Matthew Dunne, Director for Drug Discovery at Micreos Pharmaceuticals, about the importance of creating new targeted antibacterial products. ....

Jarun Ontakrai Shutterstock , Alyssa Hill , Matthew Dunne , Martin Loessner , Samuel Kilcher , Emily Henderson , Discoverymicreos Pharamceuticals , Schmelcherm Linker , Swiss Federal Institute Of Technology Zurich , Division Of Antimicrobial Vectors , University College Cork , World Health Organization , University Of Birmingham , European Molecular Biology Laboratory , Swiss Institute Of Technology , Drug Discovery At Micreos Pharmaceuticals , Micreos Pharmaceuticals , Division Of Antimicrobial Vector Innovation , Leadersmatthew Dunnedirector , Drug Discoverymicreos , World Antimicrobial Awareness Week , Drug Discovery , Antimicrobial Vector , Swiss Federal Institute , Technology Zurich , Antimicrobial Vectors ,

Micreos' Alternative to Antibiotics Secures Next €25 Million

Dutch/Swiss biotech company Micreos announced today it has secured its next funding round of €25 million in growth capital and for clinical development of its endolysin technology platform, set to replace ....

United States , United Kingdom , Mark Offerhaus , Micreos Pharma , Kostenloser Wertpapierhandel , Matt Regan , Micreos Pharmaceuticals , Technology Center , Swiss Federal Technology Institute , Development Team In Bilthoven , Over The Counter Consumer Health , Bloodstream Infections , Atopic Dermatitis , Diabetic Foot Ulcers , Cutaneoust Cell Lymphoma , Counter Consumer Health , Development Team , Micreos Food Safety , Corporate Communication Micreos ,

Micreos Secures €25M in Growth Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

United States , United Kingdom , Mark Offerhaus , Micreos Pharmaceuticals , Technology Center , Swiss Federal Technology Institute , Development Team In Bilthoven , Over The Counter Consumer Health , Bloodstream Infections , Atopic Dermatitis , Diabetic Foot Ulcers , Cutaneoust Cell Lymphoma , Counter Consumer Health , Development Team , Micreos Food Safety , Corporate Communication Micreos ,

Micreos Pharmaceuticals announces success of its XZ.700 technology in selectively eliminating Staphylococcus aureus pathogen without triggering resistance

/PRNewswire/ Micreos Pharmaceuticals today announces findings from a study proving the effectiveness of XZ.700, a novel antibacterial enzyme, in selectively. ....

Martin Loessner , Mathias Schmelcher , Micreos Pharmaceuticals , Swiss Federal Institute Of Technology , Professor Martin Loessner , Chief Scientific Officer , Swiss Federal Institute ,

Micreos Pharmaceuticals announces success of its XZ.700 technology in selectively eliminating Staphylococcus aureus path

In a new publication, the company's flagship compound proves effective in targeting the harmful pathogen. ....

Martin Loessner , Mathias Schmelcher , Micreos Pharmaceuticals , Swiss Federal Institute Of Technology , Prnewswire Micreos Pharmaceuticals , Antimicrobial Agents , Professor Martin Loessner , Chief Scientific Officer , Swiss Federal Institute ,